Personalised OMIC Lattice for Advanced Research and Improving Stratification (POLARIS) is a collaboration between A*STAR’s Genome Institute of Singapore (GIS) and SingHealth. POLARIS is an initiative within the scope of stratified medicine, which aims to deliver better patient outcomes through research.
With POLARIS, clinical researchers from various SingHealth institutions such as Singapore General Hospital, National Cancer Centre Singapore and Singapore National Eye Centre can identify critical biomarkers in patients. This will result in a more targeted approach to treating diseases.
POLARIS utilises the Next Generation Sequencing (NGS) technology in the laborataries to conduct tests. This is a fundamentally different approach to sequencing and has the ability to trigger ground-breaking discoveries, igniting a revolution in genomic science.
POLARIS is currently developing a clinical assay for corneal dystrophy. Gastrointestinal and lung cancer panels are also in development stages. POLARIS is working closely with clinicians and scientists at both SingHealth and GIS campuses.
To view the brochure of POLARIS, please click here.
For a list of SingHealth Core Platforms Equipment, click here.
Collaborations and Services
To find out more about POLARIS at SingHealth, please contact firstname.lastname@example.org